Recently Viewed

News Announcement

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Press Release / Media Release

26-Apr-2025 Follow Value Research Online on Google download pdfDownload PDF Aurobindo Pharma

Submission of Press Release that is being issue by Curateq Biologics s .r.o a wholly owned step down subsidiary of the Company in connection with the receipt of positive opinion from CHMP for Dazubys a Trastuzumab Biosimilar.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.